We are live on
!
Find out more
Compass Therapeutics
CMPX
CMPX
173 hedge funds and large institutions have $881M invested in Compass Therapeutics in 2025 Q4 according to their latest regulatory filings, with 59 funds opening new positions, 60 increasing their positions, 34 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
490% more first-time investments, than exits
New positions opened: 59 | Existing positions closed: 10
167% more funds holding in top 10
Funds holding in top 10: 3 → 8 (+5)
76% more repeat investments, than reductions
Existing positions increased: 60 | Existing positions reduced: 34
67% more capital invested
Capital invested by funds: $529M → $881M (+$353M)
38% more funds holding
Funds holding: 125 → 173 (+48)
16.95% less ownership
Funds ownership: 109.23% → 92.29% (-17%)
80% less call options, than puts
Call options by funds: $2K | Put options by funds: $10K
Holders
173
Holders Change
+48
Holders Change %
+38.4%
% of All Funds
2.1%
Holding in Top 10
8
Holding in Top 10 Change
+5
Holding in Top 10 Change %
+166.67%
% of All Funds
0.1%
New
59
Increased
60
Reduced
34
Closed
10
Calls
$2K
Puts
$10K
Net Calls
-$8K
Net Calls Change
-$3.6M
Top Buyers
| 1 |
DM
Deerfield Management
New York
|
+$16.7M |
| 2 |
BI
BVF Inc
San Francisco,
California
|
+$13.9M |
| 3 |
B
Braidwell
Stamford,
Connecticut
|
+$12.9M |
| 4 |
PAI
Palo Alto Investors
Palo Alto,
California
|
+$11.7M |
| 5 |
BlackRock
New York
|
+$9.32M |
Top Sellers
| 1 |
MB
MPM BioImpact
Boston,
Massachusetts
|
-$17.8M |
| 2 |
Blackstone Inc
New York
|
-$17.1M |
| 3 |
SCM
Silverarc Capital Management
Boston,
Massachusetts
|
-$8.23M |
| 4 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$7.84M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
-$7.19M |
